Literature DB >> 25302199

A comparative evaluation of scoring systems for assessing necro-inflammatory activity and fibrosis in liver biopsies of patients with chronic viral hepatitis.

Rahul Mannan1, Vatsala Misra2, S P Misra3, Pramela A Singh4, Manisha Dwivedi3.   

Abstract

INTRODUCTION: To compare the five scoring systems in assessing grading and staging of liver biopsies from patients with chronic viral hepatitis and their problems and pitfalls.
MATERIALS AND METHODS: Liver biopsies from 25 patients with chronic viral hepatitis were studied. Sections were stained with Haematoxylin and Eosin, Reticulin and Masson's Trichrome stains. Van Gieson, Perl's and Shikata's Orcein stains were used as and when required. Coded histological sections were scored independently by three histopathologists using the Knodell Histology Activity Index (HAI), the Scheuer scoring system, Ishak's system, Metavir system and Ishak modified HAI.
RESULTS: There were 15 males and 10 females. Their mean age was 51.24 years. On histological examination, hepatocytes showed degenerative changes with varying grades of necrosis (spotty and confluent). Widening of portal tracts with varying severity of mononuclear inflammatory infiltrate and interface hepatitis was observed. Fibrosis appeared as periportal, portal-portal and portal-central septa. A significant agreement was found by kappa statistics for both grading (p< 0.001) as well as staging (p < 0.001) among all the five scoring systems. Lobular activity was the only parameter that showed some discrepancy. No significant intra observer difference was observed.
CONCLUSION: It is concluded that all the scoring systems are equally good for grading and staging in the hands of an experienced hepatopathologists.

Entities:  

Keywords:  Fibrosis; Liver biopsy; Necro-inflammatory activity; Score

Year:  2014        PMID: 25302199      PMCID: PMC4190720          DOI: 10.7860/JCDR/2014/8704.4718

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

1.  Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

Authors:  R D Goldin; J G Goldin; A D Burt; P A Dhillon; S Hubscher; J Wyatt; N Patel
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

Review 2.  Classification of chronic viral hepatitis: a need for reassessment.

Authors:  P J Scheuer
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

3.  Histological grading and staging in chronic hepatitis: clinical applications and problems.

Authors:  S G Hübscher
Journal:  J Hepatol       Date:  1998-12       Impact factor: 25.083

4.  Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection.

Authors:  J Westin; L M Lagging; R Wejstål; G Norkrans; A P Dhillon
Journal:  Liver       Date:  1999-06

5.  The vocabulary of chronic hepatitis.

Authors:  H Popper; F Schaffner
Journal:  N Engl J Med       Date:  1971-05-20       Impact factor: 91.245

Review 6.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

Review 7.  Chronic hepatitis: morphology and nomenclature.

Authors:  K G Ishak
Journal:  Mod Pathol       Date:  1994-08       Impact factor: 7.842

8.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

9.  Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.

Authors:  D H Van Thiel; P Caraceni; P J Molloy; T Hassanein; R J Kania; A Gurakar; L Friedlander
Journal:  J Hepatol       Date:  1995-11       Impact factor: 25.083

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  8 in total

Review 1.  Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection.

Authors:  Tobias Boettler; Upkar S Gill; Lena Allweiss; Teresa Pollicino; John E Tavis; Fabien Zoulim
Journal:  JHEP Rep       Date:  2022-04-02

2.  The effect of APTR, Fn14 and CD133 expressions on liver fibrosis in biliary atresia patients.

Authors:  Akhmad Makhmudi; Reinaldo Supanji; Bayu Pratama Putra
Journal:  Pediatr Surg Int       Date:  2019-09-23       Impact factor: 1.827

3.  Comparison of magnetic resonance elastography and diffusion-weighted imaging for staging hepatic fibrosis.

Authors:  Li-Qiu Zou; Jie Chen; Liang Pan; Jin-Zhao Jiang; Wei Xing
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

4.  Silymarin Protects Mouse Liver and Kidney from Thioacetamide Induced Toxicity by Scavenging Reactive Oxygen Species and Activating PI3K-Akt Pathway.

Authors:  Shatadal Ghosh; Abhijit Sarkar; Sudip Bhattacharyya; Parames C Sil
Journal:  Front Pharmacol       Date:  2016-12-15       Impact factor: 5.810

5.  Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection.

Authors:  Zhanqing Zhang; Wei Lu; Dong Zeng; Dan Huang; Weijia Lin; Li Yan; Yanling Feng
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

Review 6.  Liver sampling: a vital window into HBV pathogenesis on the path to functional cure.

Authors:  Upkar S Gill; Laura J Pallett; Patrick T F Kennedy; Mala K Maini
Journal:  Gut       Date:  2018-01-13       Impact factor: 23.059

7.  Enhanced recovery after surgery strategy for cirrhosis patients undergoing hepatectomy: experience in a single research center.

Authors:  Yiling Zheng; Liming Wang; Fan Wu; Weiqi Rong; Yunhe Liu; Kai Zhang; Jianxiong Wu
Journal:  Ann Surg Treat Res       Date:  2020-04-28       Impact factor: 1.859

8.  Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients.

Authors:  Momen Askoura; Hisham A Abbas; Hadeel Al Sadoun; Wesam H Abdulaal; Amr S Abu Lila; Khaled Almansour; Farhan Alshammari; El-Sayed Khafagy; Tarek S Ibrahim; Wael A H Hegazy
Journal:  Pathogens       Date:  2022-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.